The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday preview: GlaxoSmithKline to report difficult quarter, analysts say

Tue, 05th Feb 2013 15:01

Healthcare giant GlaxoSmithKline is expected to report 'another difficult quarter' when the company unveils its latest results Wednesday, according to analysts.The pharmaceuticals group will post its full-year and fourth quarter financials, a day after announcing it increased its stake in its Indian consumer healthcare subsidiary by investing more than half a billion pounds in the unit. "We expect another difficult quarter as the company experiences some tough [year on year] comparisons [Advair & Cervarix], EU austerity and a forex headwind," analysts at Credit Suisse said.The broker expects a 3.0% fall in sales and 4.0% decline in earnings per share (EPS) in the fourth quarter. About £50m of incremental vaccine tenders will offset some of the negatives in the quarter but many of the headwinds look set to continue into early 2013 including its products Cervarix, Vesicare, Lamictal XR, it added.Credit Suisse said a solid dividend yield of circa 5.0% will remain an attraction for the stock along with a free cash flow generation of circa £5.0bn per annum. "We forecast an ongoing £2.0bn per annum share buyback programme to double operational EPS growth of 3-6% [2012-16 compound annual growth rate]. However, we see limited opportunity for this to improve in the near term, in the absence of significant top line growth."Shares were down 0.91% to €5.57 at 16:02.INTERIMS Hargreaves Lansdown INTERIM DIVIDEND PAYMENT DATE Ashtead Group, Halma, Vodafone Group INTERIM EX-DIVIDEND DATE Cohort, Daejan Holdings, Ingenious Entertainment VCT 1, Ingenious Entertainment VCT 1 'C' Shares, Ingenious Entertainment VCT 1 'D' Shares, Ingenious Entertainment VCT 1 E Shares, Ingenious Entertainment VCT 1 F Shares, Ingenious Entertainment VCT 2, Ingenious Entertainment VCT 2 'C' Shares, Ingenious Entertainment VCT 2 'D' Shares, Ingenious Entertainment VCT 2 F Shares, Mattioli Woods, Penna Consulting, Puma High Income VCT , Puma Vct 8, Puma Vct VII, Stagecoach Group, Tricorn Group QUARTERLY EX-DIVIDEND DATE IBM Corp., JPMorgan Claverhouse Inv Trust, Unilever INTERNATIONAL ECONOMIC ANNOUNCEMENTS PMI Construction (GER) (08:55) Q3 Canaccord Financial Inc. Q4 GlaxoSmithKline, Virgin Media Inc., Wolfson Microelectronics FINALS GlaxoSmithKline, New Europe Property Investments, Virgin Media Inc., Wolfson Microelectronics IMSS Grainger SPECIAL EX-DIVIDEND PAYMENT DATE Rensburg AIM VCT AGMS Blackrock Income And Growth Investment Trust, LED International Holdings Ltd (DI), Redhall Group UK ECONOMIC ANNOUNCEMENTS BRC Shop Price Index (00:01) New Car Registrations (09:30) FINAL DIVIDEND PAYMENT DATE Edinburgh Worldwide Inv Trust FINAL EX-DIVIDEND DATE Noble Investments (UK), Victrex Thursday February 07 INTERIMS Mcbride INTERIM DIVIDEND PAYMENT DATE FirstGroup INTERNATIONAL ECONOMIC ANNOUNCEMENTS Consumer Credit (US) (20:00) ECB Interest Rate (EU) (12:45) Industrial Production (GER) (11:00) Productivity (US) (13:30) Q4 Smith & Nephew FINALS Beazley, Smith & Nephew IMSS Avon Rubber, Supergroup, Vodafone Group EGMS Hotel Corporation (The) AGMS Avon Rubber, BlackRock New Energy Inv Trust, Compass Group, Downing Absolute Income VCT 1, Downing Absolute Income VCT 1 'C' Shares , Downing Income Vct, Downing Income Vct 4, Paragon Group Of Companies, Thomas Cook Group, TUI Travel, Unicorn AIM VCT TRADING ANNOUNCEMENTS Bellway UK ECONOMIC ANNOUNCEMENTS Balance of Trade (09:30) BoE Interest Rate Decision (12:00) FINAL DIVIDEND PAYMENT DATE Cardiff Property, JPMorgan Asian Inv Trust Q1 TUI Travel, TUI Travel
More News
Today 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
Today 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
Today 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
Today 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
Today 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.